Steven Pratt
AbbVie (United States)(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Prion Diseases and Protein Misfolding, Peptidase Inhibition and Analysis, HIV Research and Treatment, Pneumonia and Respiratory Infections
Most-Cited Works
- → Library Design, Synthesis, and Screening: Pyridine Dicarbonitriles as Potential Prion Disease Therapeutics(2005)127 cited
- → The Structure of VanX Reveals a Novel Amino-Dipeptidase Involved in Mediating Transposon-Based Vancomycin Resistance(1998)92 cited
- → Synthesis and evaluation of a focused library of pyridine dicarbonitriles against prion disease(2007)76 cited
- → Induction of Ribosome Methylation in MLS-Resistant Streptococcus pneumoniae by Macrolides and Ketolides(1999)50 cited
- → Sphingolipid synthesis and scavenging in the intracellular apicomplexan parasite, Toxoplasma gondii(2012)41 cited
- → Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance(2005)39 cited
- → The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy(2022)38 cited
- → A Strategy for Discovery of Novel Broad-Spectrum Antibacterials Using a High-Throughput Streptococcus pneumoniae Transcription/Translation Screen(2004)33 cited
- → Phenotypic anchoring of arsenic and cadmium toxicity in three hepatic-related cell systems reveals compound- and cell-specific selective up-regulation of stress protein expression: Implications for fingerprint profiling of cytotoxicity(2006)27 cited
- → Squamous cell carcinoma of the stomach: A study of four patients with comments on histogenesis(1985)25 cited